(4'-Pentyl[1,1'-biphenyl]-4-yl)boronic acid, 95.0%, 5g

3β-Ursodeoxycholic acid, 10mg

Ethyl 4-(3-Chloro-5-fluorophenyl)-4-oxobutanoate, 97.0%, 1g

3-(5-methoxy-1H-benzimidazol-2-yl)propanoic acid hydrochloride, 95.0%, 1g

2-(2-Chloro-6-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

(1-(1-ETHOXY-1-OXOBUTAN-2-YL)-1H-PYRAZOL-4-YL)BORONIC ACID PINACOL ESTER, 95.0%, 5g

2-Acetylbenzaldehyde, 97%, 1g

5-Chloromethyl-3-(3,4-dichloro-phenoxymethyl)-[1,2,4]oxadiazole, 5g

4-{[(Diaminomethylidene)amino]methyl}benzoic acid hydrate, 50mg

N,N,N',N'-Tetramethyldiaminomethane>98.0%(GC)(T)500mL

Methyl 2,6-dichloro-4-iodobenzoate, 95+%, 250mg

2-Azaspiro[3.3]heptan-6-ol hydrochloride, 95.0%, 500mg

Alpha chloralose, max 20% beta anomer, 250 g, plastic packaging.